Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Total Non-Current Liabilities: 2020-2024

Historic Total Non-Current Liabilities for Oncology Institute (TOI) over the last 5 years, with FY2024 value amounting to $168.7 million.

  • Oncology Institute's Total Non-Current Liabilities fell 58.34% to $162.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $162.2 million, marking a year-over-year decrease of 58.34%. This contributed to the annual value of $168.7 million for FY2024, which is 1314.93% up from last year.
  • Per Oncology Institute's latest filing, its Total Non-Current Liabilities stood at $168.7 million for FY2024, which was up 1314.93% from $149.1 million recorded in FY2023.
  • Oncology Institute's Total Non-Current Liabilities' 5-year high stood at $168.7 million during FY2024, with a 5-year trough of $36.8 million in FY2020.
  • Over the past 5 years, Oncology Institute's median Total Non-Current Liabilities value was $134.5 million (recorded in 2022), while the average stood at $116.3 million.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first surged by 15116.23% in 2021, then soared by 1085.48% in 2023.
  • Over the past 5 years, Oncology Institute's Total Non-Current Liabilities (Annual) stood at $36.8 million in 2020, then soared by 151.16% to $92.4 million in 2021, then soared by 45.63% to $134.5 million in 2022, then increased by 10.85% to $149.1 million in 2023, then rose by 13.15% to $168.7 million in 2024.
  • Its Total Non-Current Liabilities stands at $168.7 million for FY2024, versus $149.1 million for FY2023 and $134.5 million for FY2022.